Therapeutic role of interleukin-1 receptor antagonist in pancreatic diseases: mendelian randomization study
BackgroundThe interleukin-1 pathway has been linked to pancreatic diseases. We applied the Mendelian randomization approach to explore whether higher interleukin-1 receptor antagonist (IL-1RA) levels reduce the risk of acute and chronic pancreatitis and pancreatic cancer.MethodsGenetic variants asso...
Main Authors: | Shuai Yuan, Yuyang Miao, Xixian Ruan, Jie Chen, Xue Li, Susanna C. Larsson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1240754/full |
Similar Items
-
Genetically predicted causal link between the plasma lipidome and pancreatic diseases: a bidirectional Mendelian randomization study
by: Liaoyi Lin, et al.
Published: (2025-01-01) -
The causality between use of glucocorticoids and risk of pancreatitis: a Mendelian randomization study
by: Wenfeng Lin, et al.
Published: (2024-08-01) -
Lipid levels and risk of acute pancreatitis using bidirectional Mendelian randomization
by: Biqi Wang, et al.
Published: (2024-03-01) -
Causal Exposures in Pancreatic Cancer Incidence: Insights From Mendelian Randomization Studies
by: Ashraf Mohamadkhani, et al.
Published: (2025-02-01) -
Exploring lipidome mediated inflammatory pathways in acute pancreatitis using mendelian randomization
by: Wenbin Liu, et al.
Published: (2025-01-01)